Biggest News Aggregation in the World
📰 Clinical Course News

Clinical Course News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Course. Real-time updates on events, politics, business and more.

Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients

/PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the publication of findings from a retrospective chart review of...
United States San Francisco New York Derek Belz Mary Mcgowan Data Sciences

Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, recently shared findings from Mallinckrodts latest health...
United States Danielj Speciale Prnewswire Mallinckrodt Derek Belz Drug Administration American College Of Chest Physicians

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cureus | Eclampsia and Postpartum Depression in the Setting of Recurrent Prenatal COVID-19

Current research suggests COVID-19 in pregnancy is associated with poor maternal and fetal outcomes, although the exact mechanisms remain unclear, and the approach to the management of affected patients presents a distinct challenge to clinicians. We present a case of gestational hypertension, eclampsia, and postpartum depression in a 39-year-old gravida 4, para 0030 (G4P0) pregnant patient following multiple prenatal severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection...
Emergency Department World Health Organization Cohort Study Edinburgh Postnatal Depression Clinical Course
Source: cureus.com

Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business Update

08.08.2022 - – Initiated a Phase 1 trial of VGL101 in healthy volunteers in Australia – – Received U.S. FDA orphan drug designation for VGL101 for the treatment of patients with ALSP – – Prioritizing VGL101 in ALSP and small molecule TREM2 agonist programs; ...
United Kingdom Suzanne Bruhn Ivana Magov Megan Mcgrath Macdougall Exchange Commission Agonist Program

Frontiers | Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients

2Department of Microbiology, Linyi Center for Disease Control and Prevention, Linyi, China 3Department of Immunology, School of Basic Medicine, Qingdao University, Qingdao, China 4Department of Infectious Disease, The Affiliated Hospital of Qingdao University, Qingdao, China 5Department of Medical Education, Qingdao Chest Hospital, Qingdao, China 6Department of Infectious Disease, Qingdao Centre for Disease Control and Prevention, Qingdao Institute of Prevention Medicine, Qingdao, China 7Instit...
South Korea United States Genet Evol Mateos Gonz Nat Microbiol Eosinopeniaj Microbiol

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science